Multimodal data means putting together different kinds of health information about patients. This includes clinical records, molecular data like DNA tests, gene variations, behavior details, and even environmental information. When you combine all these, you get a better picture of a patient’s health than using just one type of data.
In cancer care, for example, molecular data from tumor and normal tissue tests mixed with clinical records helps doctors find unique traits in patients. This supports precision medicine. Precision medicine means making treatment plans that fit each patient’s biology and health, not just using the same method for everyone.
Using real-world data from daily healthcare — such as test results, how patients respond to treatments, and reports from patients themselves — gives doctors bigger and more varied patient information than clinical trials alone. This leads to treatments that work better for each person.
An example is Tempus, a company that works with about 65% of academic medical centers and over half of cancer doctors in the US. They handle more than 300 petabytes of real-world multimodal data and over 8 million anonymous patient records. Companies like Tempus give doctors tools based on data to make smarter treatment choices. These tools can match patients to clinical trials, predict how well treatments will work, and help diagnose diseases earlier.
One big benefit of using different types of data together is that doctors can find new treatment targets and guess how patients might respond to certain therapies. Regular tests might miss important changes in tumors, limiting treatment options. But using liquid biopsies (blood tests) together with tumor tests shows more information.
This combined method helps find genetic markers that might be missed otherwise, allowing doctors to tailor treatments more precisely.
For medical practice administrators and IT managers, systems that analyze large multimodal data sets provide:
These improvements are not just for cancer care; data integration is also used in other fields like heart care. For instance, Tempus’s FDA-approved Tempus ECG-AF algorithm finds patients at high risk for atrial fibrillation, a common heart rhythm problem. This is one of the first uses of AI in heart diagnostics and shows how AI plus multimodal data can make risk detection and disease care better.
Medical practices have many challenges like handling large amounts of patient data, coordinating care well, and giving timely, personalized treatment. Having multimodal data and AI tools helps solve these problems.
These tools show how technology helps make healthcare more personal and efficient. Medical leaders in the US, like administrators and IT managers, should know the benefits of working with data companies skilled in AI and multimodal data to keep up with healthcare demands.
Another important use of AI is helping with healthcare office tasks, especially in front-office work. Scheduling, handling calls, sending appointment reminders, and answering common questions can create large workloads and slow down operations.
AI phone automation services, such as those from Simbo AI, address these problems. Using AI for answering and routing calls can:
For US healthcare administrators and office managers, automating front-office tasks with AI not only improves patient experiences but also helps clinical outcomes by making sure patients get care and follow-ups on time.
AI automation also helps in clinical areas by supporting data entry, billing, and medical record management. This lowers costs and cuts down errors caused by manual work.
Putting AI tools into daily work fits with current healthcare goals to improve care without adding extra administrative work.
Clinical research, especially tests for new drugs or treatments, is a big part of modern healthcare. AI’s skill in analyzing multimodal data has changed how patients are enrolled in clinical trials by quickly matching them with studies based on their biological and health records.
For practice administrators and owners in the US, this brings better treatment options and more chances to join research. Recent data shows Tempus has found over 30,000 patients who could join clinical trials, speeding up patient enrollment and possibly helping outcomes.
AI-driven trial matching cuts delays and helps eligible patients get new treatments earlier. It also supports research by creating large reports from real-world data that help set future treatment rules.
Big healthcare data solutions depend on teamwork among academic medical centers, drug companies, and biotech firms. In the US, many academic centers and cancer specialists use AI platforms like Tempus. About 65% of academic centers and 50% of cancer doctors use it.
Drug companies also use these platforms for developing medicines. More than 95% of the top 20 pharma cancer companies work with Tempus, which partners with over 200 biopharma firms. These partnerships let them share anonymous research data to help create new drugs and personalized treatments.
Medical practice leaders in the US should think about these partnerships when choosing data platforms to make sure their organizations get the latest research and treatment options.
Putting in place multimodal data analysis and AI tools needs good planning in healthcare settings, including:
Administrators and IT managers should work closely with vendors and clinical teams to make plans that fit their patient groups and practice sizes.
Healthcare in the United States is moving toward a future where multimodal real-world data and AI support more personalized, accurate, and timely patient care. Medical practice administrators, owners, and IT managers play an important role in bringing in these technologies by investing in data platforms, improving workflow automation, and supporting clinical research. Organizations that use these tools can improve patient satisfaction, clinical results, and operational efficiency in a competitive healthcare market.
AI-enabled precision medicine uses artificial intelligence to enhance patient care by accelerating the discovery of new treatment targets, predicting treatment effectiveness, and identifying suitable clinical trials, ultimately allowing for earlier diagnoses of various diseases.
AI can help healthcare providers make more informed treatment decisions by analyzing large volumes of data, identifying care gaps, and providing tailored insights that lead to better patient outcomes.
AI can efficiently handle high call volumes, reducing wait times for patients, streamlining appointment scheduling, and improving overall patient engagement, which enhances the patient experience.
AI assists in clinical trial matching by analyzing patient data and identifying individuals who may qualify for specific trials, increasing the chances of successful enrollment and outcomes.
Tempus partners with over 95% of the top 20 pharmaceutical companies in oncology by providing molecular profiling and data-driven insights to enhance drug development and treatment personalization.
Tempus utilizes multimodal real-world data, including genomic, clinical, and behavioral data, helping to provide comprehensive insights into patient care and treatment options.
AI improves patient care by enabling high-quality testing, efficient trial matching, and deep analysis of research data, all contributing to better patient outcomes.
Olivia is an AI-enabled personal health concierge app designed for patients and caregivers to help them manage, organize, and proactively control their health data.
Tempus launched a collaboration with BioNTech for real-world data usage and received FDA clearance for its AI-based Tempus ECG-AF device to identify patients at risk of atrial fibrillation.
AI accelerates the identification of novel therapeutic targets, enhancing the speed and accuracy of treatment development in precision medicine, which is critical in improving patient outcomes in complex diseases.